Click CAR-T cell engineering for robustly boosting cell immunotherapy in blood and subcutaneous xenograft tumor
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Click CAR-T cell engineering for robustly boosting cell immunotherapy in blood and subcutaneous xenograft tumor
Authors
Keywords
CAR-T cell, Bioorthogonal click chemistry, Glycometabolic labeling, Off-target effects, Cell immunotherapy
Journal
Bioactive Materials
Volume 6, Issue 4, Pages 951-962
Publisher
Elsevier BV
Online
2020-10-09
DOI
10.1016/j.bioactmat.2020.09.025
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hyperspectral cell sociology reveals spatial tumor-immune cell interactions associated with lung cancer recurrence
- (2019) Katey S. S. Enfield et al. Journal for ImmunoTherapy of Cancer
- CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape
- (2019) Mohamad Hamieh et al. NATURE
- Enhancing tumor T cell infiltration to enable cancer immunotherapy
- (2019) Jin Zhang et al. Immunotherapy
- Glycometabolic Bioorthogonal Chemistry‐Guided Viral Transduction for Robust Human T Cell Engineering
- (2019) Hong Pan et al. ADVANCED FUNCTIONAL MATERIALS
- T Cell Membrane Mimicking Nanoparticles with Bioorthogonal Targeting and Immune Recognition for Enhanced Photothermal Therapy
- (2019) Yutong Han et al. Advanced Science
- Endogenous T cells prevent tumor immune escape following adoptive T cell therapy
- (2019) Scott R. Walsh et al. JOURNAL OF CLINICAL INVESTIGATION
- An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
- (2019) Caroline S. Jansen et al. NATURE
- IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor
- (2018) Keishi Adachi et al. NATURE BIOTECHNOLOGY
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- CAR-T cells: the long and winding road to solid tumors
- (2018) Maria Michela D’Aloia et al. Cell Death & Disease
- Junctional Adhesion Molecules (JAMs): The JAM-Integrin Connection
- (2018) Daniel Kummer et al. Cells
- Dissecting complicated viral spreading of enterovirus 71 using in situ bioorthogonal fluorescent labeling
- (2018) Hong Pan et al. BIOMATERIALS
- Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
- (2018) Elena J. Orlando et al. NATURE MEDICINE
- Tumor Antigen Escape from CAR T-cell Therapy
- (2018) Robbie G. Majzner et al. Cancer Discovery
- Bio-Orthogonal T Cell Targeting Strategy for Robustly Enhancing Cytotoxicity against Tumor Cells
- (2018) Wenjun Li et al. Small
- Cyclopropenones for Metabolic Targeting and Sequential Bioorthogonal Labeling
- (2017) R. David Row et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
- (2017) Terry J Fry et al. NATURE MEDICINE
- In Situ Bioorthogonal Metabolic Labeling for Fluorescence Imaging of Virus Infection In Vivo
- (2017) Hong Pan et al. Small
- Increasing Tumor-Infiltrating T Cells through Inhibition of CXCL12 with NOX-A12 Synergizes with PD-1 Blockade
- (2017) Dirk Zboralski et al. Cancer Immunology Research
- Global Manufacturing of CAR T Cell Therapy
- (2017) Bruce L. Levine et al. Molecular Therapy-Methods & Clinical Development
- Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting
- (2016) Clare Y. Slaney et al. CLINICAL CANCER RESEARCH
- Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
- (2016) Hanren Dai et al. JNCI-Journal of the National Cancer Institute
- Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies
- (2016) David T. Rodgers et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
- (2016) Hanren Dai et al. JNCI-Journal of the National Cancer Institute
- T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells
- (2016) E. Zah et al. Cancer Immunology Research
- Systemic Fluorescence Imaging of Zebrafish Glycans with Bioorthogonal Chemistry
- (2015) Paresh Agarwal et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Genetically modified T cells in cancer therapy: opportunities and challenges
- (2015) M. Sharpe et al. Disease Models & Mechanisms
- Bioorthogonal Click Chemistry-Based Synthetic Cell Glue
- (2015) Heebeom Koo et al. Small
- Noninvasive Visualization of Respiratory Viral Infection Using Bioorthogonal Conjugated Near-Infrared-Emitting Quantum Dots
- (2014) Hong Pan et al. ACS Nano
- Enhancement of T cell recruitment and infiltration into tumours
- (2014) C. Oelkrug et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
- (2014) G. L. Beatty et al. CLINICAL CANCER RESEARCH
- Anti-tumor activity of obinutuzumab and rituximab in a follicular lymphoma 3D model
- (2013) E Decaup et al. Blood Cancer Journal
- A Non-Fluorinated Monobenzocyclooctyne for Rapid Copper-Free Click Reactions
- (2011) Balázs R. Varga et al. CHEMISTRY-A EUROPEAN JOURNAL
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now